Vascular endothelial growth factor (VEGF) contributes to several immunosuppressive pathways, but chiefly drives tumour angiogenesis resulting in an abnormal vascular architecture that prevents infiltration by circulating CTLs (step 3; Figure 1) [81]. This evidence concerns the gene VEGFA and neoplasm.